Aug 11, 2025
11:10
For every 10 shares held, investors received 11. The price per share adjusted from $18.70 to $17.00.
The split itself did not change the total investment value.
RBC Bioscience Corporation (TPEX:6848) operates in the Biotechnology industry.
RBC Bioscience Corporation company overviewRBC Bioscience Corporation's most recent stock split was on August 11, 2025. It was a 11-for-10 forward split, so shareholders received 11 shares for every 10 they held.
RBC Bioscience Corporation (TPEX:6848) has split its stock 2 times: a 11-for-10 split on July 21, 2022 and a 11-for-10 split on August 11, 2025.
RBC Bioscience Corporation has split its stock 2 times. This history records 2 forward splits between July 21, 2022 and August 11, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In RBC Bioscience Corporation's 11-for-10 split on August 11, 2025, every 10 shares became 11 shares.
RBC Bioscience Corporation has not announced a new split in our records. Its most recent split was on August 11, 2025, 1 year ago. Companies announce splits in advance, and any new TPEX:6848 split will appear on this page.
Already premium?